Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fennec Pharmaceuticals (FENC) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to $152000.0.

  • Fennec Pharmaceuticals' Interest & Investment Income fell 7054.26% to $152000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $958000.0, marking a year-over-year decrease of 3147.35%. This contributed to the annual value of $1.7 million for FY2024, which is 28140.59% up from last year.
  • As of Q3 2025, Fennec Pharmaceuticals' Interest & Investment Income stood at $152000.0, which was down 7054.26% from $171000.0 recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Interest & Investment Income ranged from a high of $570000.0 in Q2 2024 and a low of $9000.0 during Q1 2022
  • Over the past 5 years, Fennec Pharmaceuticals' median Interest & Investment Income value was $115000.0 (recorded in 2023), while the average stood at $162166.7.
  • As far as peak fluctuations go, Fennec Pharmaceuticals' Interest & Investment Income skyrocketed by 117777.78% in 2023, and later crashed by 7054.26% in 2025.
  • Fennec Pharmaceuticals' Interest & Investment Income (Quarter) stood at $13000.0 in 2021, then surged by 1084.62% to $154000.0 in 2022, then decreased by 25.32% to $115000.0 in 2023, then surged by 246.96% to $399000.0 in 2024, then crashed by 61.9% to $152000.0 in 2025.
  • Its Interest & Investment Income stands at $152000.0 for Q3 2025, versus $171000.0 for Q2 2025 and $236000.0 for Q1 2025.